Items where authors include "Barberio, B"
Article
Barberio, B, Gracie, DJ, Black, CJ et al. (1 more author) (2023) Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn’s disease: systematic review and network meta-analysis. Gut, 72 (2). pp. 264-274. ISSN 0017-5749
Visaggi, P, Ghisa, M, Barberio, B et al. (7 more authors) (2023) Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials. Digestive and Liver Disease, 55 (2). pp. 208-222. ISSN 1590-8658
Barberio, B, Gracie, DJ, Black, CJ et al. (1 more author) (2023) Impact of Baseline Disease Activity and Trial Duration on Efficacy of Biologics in Active Crohn’s Disease: Meta-analysis. Inflammatory Bowel Diseases. izac263. ISSN 1078-0998
Fairbrass, KM orcid.org/0000-0002-5569-4762, Lovatt, J, Barberio, B et al. (3 more authors) (2022) Bidirectional brain–gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis. Gut, 71 (9). pp. 1773-1780. ISSN 0017-5749
Savarino, E, Zingone, F, Barberio, B et al. (27 more authors) (2022) Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility. United European Gastroenterology Journal, 10 (6). pp. 556-584. ISSN 2050-6406
Barberio, B, Savarino, EV, Black, CJ et al. (1 more author) (2022) Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta‐analysis. Neurogastroenterology & Motility, 34 (6). e14279. ISSN 1350-1925
Barberio, B, Savarino, EV, Black, CJ et al. (1 more author) (2022) Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-analysis. Clinical Gastroenterology and Hepatology, 20 (5). E923-E944. ISSN 1542-3565
Barberio, B, Facchin, S, Patuzzi, I et al. (8 more authors) (2022) A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach. Gut Microbes, 14 (1). e2028366. ISSN 1949-0976
Barberio, B, Yiannakou, Y, Houghton, LA orcid.org/0000-0002-5351-0229 et al. (3 more authors) (2022) Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-up Study. Clinical Gastroenterology and Hepatology, 20 (2). E89-E101. ISSN 1542-3565
Barberio, B, Massimi, D, Cazzagon, N et al. (3 more authors) (2021) Prevalence of Primary Sclerosing Cholangitis in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Gastroenterology, 161 (6). pp. 1865-1877. ISSN 0016-5085
Tasson, L, Zingone, F, Barberio, B et al. (7 more authors) (2021) Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases. Scientific Reports, 11 (1). 15251. ISSN 2045-2322
Barberio, B, Segal, JP, Quraishi, MN et al. (3 more authors) (2021) Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis. Journal of Crohn's and Colitis, 15 (7). pp. 1184-1196. ISSN 1873-9946
Barberio, B, Judge, C, Savarino, EV et al. (1 more author) (2021) Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis. The Lancet Gastroenterology and Hepatology. ISSN 2468-1253
Barberio, B, Zamani, M, Black, CJ et al. (2 more authors) (2021) Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 6 (5). pp. 359-370. ISSN 2468-1253
Barberio, B, Black, CJ, Savarino, EV et al. (1 more author) (2020) Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis. Journal of Crohn's and Colitis. ISSN 1873-9946
Barberio, B, Houghton, LA, Yiannakou, Y et al. (3 more authors) (2020) Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome. American Journal of Gastroenterology. ISSN 0002-9270
Barberio, B, Mahadeva, S, Black, CJ et al. (2 more authors) (2020) Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria. Alimentary Pharmacology & Therapeutics, 52 (5). pp. 762-773. ISSN 0269-2813
Oka, P, Parr, H, Barberio, B et al. (3 more authors) (2020) Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. ISSN 2468-1253